
PARKINSON’S DISEASE
Review: Hallett M and Litvan I. Evaluation of surgery for Parkinson’s disease: A report of the
Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
Neurology 1999;53:1910-1921.
Review: Ferreira J and Rascol O. Prevention and therapeutic strategies for levodopa-induced dyskinesias
in Parkinson’s disease. Curr Opinion Neurol 2000;13:431-436.
Review: Wolters E and Berendse H. Management of psychosis in Parkinson’s disease. Curr Opinion
Neurol 2001;14:499-504.
Review: Miyasaki J, Martin W, et al. Practice parameter: Initiation of treatment for Parkinson’s disease:
An evidence-based review. Neurol 2002;58:11-17.
Review: Korczyn A and Nussbaum M. Emerging therapies in the pharmacological treatment of
Parkinson’s disease. Drugs 2002;62:775-786.
Review: Pollack P, Fraix V, et al. Treatment results: Parkinson’s disease. Movement Disorders 2002;17
(supp3):S75-83.
Comela C, Stebbins G, et al. Physical Therapy and Parkinson’s disease: A controlled clinical trial Neurol
1994;44:376-378.
Parkinson Study Group. Impact of deprenyl and tocopherol treatment on Parkinson’s disease in DATATOP
patients requiring levodopa. Ann Neurol 1966;39:37-45.
Parkinson Study Group. Impact of deprenyl and tocopherol treatment on Parkinson’s disease in
DATATOP subjects not requiring levodopa. Ann Neurol 1996;39:29-36.
Koller W, Hutton T et al. Immediate-release and controlled-release carbidopa/levodopa in PD: A 5-year
randomized multicenter study. Neurol 1999;53:1012-1019.
Pepper P and Goldstein M. Postoperative complications in Parkinson’s disease. JAGS 1999;47:967-972.
Fenelon G, Mahieux F, et al. Hallucinations in Parkinson’s disease: Prevalence, phenomenology and risk
factors. Brain 2000;123:733-745.
Rascol O, Brooks D et al. A five-year study of the incidence of dyskinesia in patients with early
Parkinson’s disease who were treated with ropinerole or levodopa. NEJM 2000;342:1484-1491.
Parkinson Study Group. Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized
controlled trial. JAMA 2000;284:1931-1938.
Tsang K, Ho S and Lo S. Estrogen improves motor disability in parkinsonian postmenopausal women with
motor fluctuations. Neurol 2000;54:2292-2298.
Lees A, Katzenschlager R et al. Ten-year follow-up of three different initial treatments in de-novo PD: A
randomized trial. Neurol 2000;57:1687-1694.
Freed C, Greene P et al. Transplantation of embryonic dopamine neurons for severe Parkinson’s disease.
NEJM 2002;344:710-719.
Hobson D, Lang A, et al. Excessive daytime sleepiness and sudden-onset sleep in Parkinson’s disease: A
survey by the Canadian Movement Disorders Group. JAMA 2002;287:455-463.
Krack P, Batir A, Van Blercom N et al. Five-Year Folow-up of Bilateral Stimulation of the Subthalamic
Nucleus in Advanced Parkinson’s Disease. NEJM 2003;348:1925-1934.